Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a ... - MyChesCo

Retrieved on: 2023-09-14 20:10:56

Tags for this article:

COVID-19 vaccination in the United States

RNA vaccines

Medical research

Arbutus Biopharma

PD-1 and PD-L1 inhibitors

Pfizer-BioNTech COVID-19 vaccine

Pfizer

Moderna COVID-19 vaccine

Click the tags to see associated articles and topics

Arbutus Announces Pipeline Updates and Dosing of the First Subject in the Phase 1a ... - MyChesCo. View article details on HISWAI: https://www.mychesco.com/a/news/regional/arbutus-announces-pipeline-updates-and-dosing-of-the-first-subject-in-the-phase-1a-1b-clinical-trial-with-ab-101-cash-runway-extended/

Excerpt

WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) this week announced pipeline updates including its continued focus on its hepatitis ...

Article found on: www.mychesco.com

View Original Article